Solid Biosciences Inc.

Most Recent

  • uploads///molecule _
    Company & Industry Overviews

    Why Solid Biosciences Stock Nosedived 67.82% Yesterday

    On February 7, Solid Biosciences (SLDB) closed at $7.19, 67.82% lower than its previous closing price.

    By Margaret Patrick
  • uploads///SLDB pipeline
    Company & Industry Overviews

    Solid Biosciences and Its Focus on Duchenne Muscular Dystrophy

    In the fourth quarter of 2017, Solid Biosciences initiated a Phase 1/2 clinical trial called IGNITE DMD to test SGT-001 in the United States.

    By Kenneth Smith
  • uploads///blood _
    Company & Industry Overviews

    BioMarin Pharmaceutical and Its Promising Research Pipeline

    Stocks focused on gene therapy have garnered strong investor interest in 2018. In this series, we’ll analyze four of those companies.

    By Kenneth Smith
  • uploads///koli bacteria _
    Company & Industry Overviews

    Why resTORbio Stock Is Seeing Solid Growth Today

    Today, resTORbio (TORC) is trading at $13.36, which represents 48.28% growth from yesterday when it was trading at $9.01.

    By Daniel Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.